Solventum Corporation (FRA:KB7)

Market Cap	11.24B -7.1%
Revenue (ttm)	7.16B +2.3%
Net Income	1.30B +111.7%
EPS	7.43 +110.2%
Shares Out	n/a
PE Ratio	8.65
Forward PE	12.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	95
Open	62.80
Previous Close	63.80
Day's Range	62.80 - 62.80
52-Week Range	54.40 - 80.50
Beta	n/a
RSI	35.08
Earnings Date	Feb 20, 2026

About Solventum

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical e...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2023
• Employees: 22,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KB7

Financial Performance

In 2024, Solventum's revenue was $8.25 billion, an increase of 0.70% compared to the previous year's $8.20 billion. Earnings were $479.00 million, a decrease of -64.41%.

Financial numbers in USD